Ian D. Pavord
Expertise in
10
conditions

Ian D. Pavord

Oxford, ENG, GB 
Expertise in
10
conditions
Oxford, ENG, GB 

Overview

Ian Pavord practices in Oxford, United Kingdom. Mr. Pavord is highly rated in 10 conditions, according to our data. His top areas of expertise are Eosinophilic Asthma, Asthma, Chronic Cough, and Chronic Obstructive Pulmonary Disease (COPD).

His clinical research consists of co-authoring 445 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Oxford, ENG, United Kingdom
Other Locations
Radcliffe On Trent, ENG, United Kingdom
Nuffield, ENG, United Kingdom
United Kingdom
Newcastle Upon Tyne, ENG, United Kingdom
Leicester, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised Pragmatic Trial Of Corticosteroid Optimisation In Severe Asthma Using A Composite Biomarker Algorithm To Adjust Corticosteroid Dose Versus Standard Care
A Randomised Pragmatic Trial Of Corticosteroid Optimisation In Severe Asthma Using A Composite Biomarker Algorithm To Adjust Corticosteroid Dose Versus Standard Care
Enrollment Status: Completed
Publish Date: June 25, 2020
Intervention Type: Other
Study Phase: Not Applicable

445 Total Publications

Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asthma (HOTHOT).
Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asthma (HOTHOT).
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: January 30, 2026

Frequently Asked Questions about Ian D. Pavord

Is Ian D. Pavord a top-rated expert for Eosinophilic Asthma?

MediFind is an objective health platform that identifies experts based on real-world data. Ian D. Pavord is classified as an Elite expert for Eosinophilic Asthma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ian D. Pavord participate in research or clinical trials?

Yes. Ian D. Pavord has published 445 articles and abstracts on conditions like Eosinophilic Asthma. You can view a list of Ian D. Pavord's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pavord's expertise for a condition
ConditionClose
View All 8 Elite Conditions
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile